Efficiency of glydiab in therapy of patients with type 2 diabetes mellitus

Cover Page
Open Access Open Access
Restricted Access Subscription Access

Abstract


Russian drug glydiab (Akrikhin, Russia) regulates basal and postprandial glycemia, glycated hemoglobin, and C peptide, normalizes lipid metabolism, arterial pressure, body weight, and lipid peroxidation in 82% patients with type 2 diabetes mellitus. An important clinical and pathogenetic characteristic of glydiab is prevention of excessive insulin production. Presumably, activation of antioxidant defense leads to improvement of insulin receptor interactions and insulin sensitivity. Glydiab is easy to use, well tolerated, easily available, and is recommended for the treatment of patients with type 2 diabetes mellitus.


V. A. Galenok

Novosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City

Author for correspondence.
Email: probl@endojournals.ru

Russian Federation

I. A. Krivosheeva

Novosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City

Email: probl@endojournals.ru

Russian Federation

O. V. Sazonova

Novosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City

Email: probl@endojournals.ru

Russian Federation

E. A. Yedemskaya

Novosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City

Email: probl@endojournals.ru

Russian Federation

  1. Балаболкин М. И. Диабетология. - М., 2000.
  2. Дедов И. И., Фадеев В. В. Введение в диабетологию: Руководство для врачей. - М., 1998.
  3. Никифоров О. А. Перекисное окисление липидов и система антиоксидантной защиты у больных сахарным диабетом 1 типа: Дис. ... канд. мед. наук. - Новосибирск, 1999.
  4. Планирование и проведение клинических исследований лекарственных средств / Под ред. Ю. Б. Белоусова. - М., 2000.
  5. Таранов А. Г. Диагностические тест-системы. Радиоиммунный и иммуноферментный методы диагностики. - Новосибирск, 2000.
  6. Фадеева Н. И., Балаболкин М. И., Мамаева Г. Г. и др. // Сахарный диабет. - 2001. - № 1. - С. 21-23.
  7. Turner R. С. Matthews D R., Clark A. et al. // Baillieres Clin. Endocrinol. Metab. - 1998. - Vol. 12, N 2. - P 327-342.
  8. UK Prospective Diabetes Study (UKPDS) Group // Lancet. - 1998. - Vol. 352. - P. 837-853.

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 2002 Galenok V.A., Krivosheeva I.A., Sazonova O.V., Yedemskaya E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies